ReviewImmunotherapy advances2021
100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes.
James A Pearson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewImmunotherapy advances2021
James A Pearson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.